PERLE BIOSCIENCE, INC.

Profile

Company Names

PERLE BIOSCIENCE, INC.

Addresses

520 FOLLY ROAD, SUITE P212, CHARLESTON, SC 29412

2250 CHRYSLER TERRACE, NE, ATLANTA, GA 30345

Phone Numbers

843-568-2603

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$4,733,239.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2015-11-24 
$1,798,500.00 
$2,750,000.00 
$951,500.00 
Equity 
1
2014-04-17 
$2,934,739.00 
$3,300,000.00 
$365,261.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUGLAS 
 
CARNES 
DIRECTOR
MINIVAX, INC.   |  PERLE BIOSCIENCE, INC.
RYAN 
N. 
FIORINI 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOLOGIX, INC.   |  PERLE BIOSCIENCE, INC.   |  BLINKTBI, INC.
DONNA 
 
HILL 
DIRECTOR
PERLE BIOSCIENCE, INC.
CLARESA 
 
LEVETAN 
EXECUTIVE OFFICER, DIRECTOR
PERLE BIOSCIENCE, INC.
GILBERT 
 
NATHAN 
DIRECTOR
PERLE BIOSCIENCE, INC.   |  EMERGENT CAPITAL, INC.
LLOYD 
A. 
PEARSON 
EXECUTIVE OFFICER
IMMUNOLOGIX, INC.   |  KERDEA TECHNOLOGIES, INC.   |  PERLE BIOSCIENCE, INC.
JEFFREY 
 
RILEY 
DIRECTOR
SYNTHETIC BIOLOGICS, INC.   |  PERLE BIOSCIENCE, INC.   |  GAIN THERAPEUTICS, INC.   |  BLINKTBI, INC.   |  CARAVAN BIOLOGIX, INC.   |  GALENA INNOVATIONS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-12-30
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-24 
2015-12-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-24 
2014-07-28
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-17 
2014-06-25
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-17 
2014-04-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#